Browse by author
Lookup NU author(s): Andrew Jobson,
Dr Elaine WillmoreORCiD,
Dr Michael Tilby,
Professor Caroline AustinORCiD
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Purpose: Previous in vitro cleavage data showed that XR11576 and XR5944 stabilised topoisomerase I and topoisomerase II complexes on DNA in a dose-dependent fashion. However, some studies indicated a possible topoisomerase-independent mechanism of action for these drugs. Methods: Three methods, the TARDIS assay, immunoband depletion and the K+/SDS assay have been used to assess topoisomerase complex formation induced by XR11576 or XR5944 in human leukaemic K562 cells. Results: TARDIS and immunoband depletion assays demonstrated that XR11576 and XR5944 induced complex formation for both topoisomerase I and topoisomerase II (alpha and beta) in a dose- and time-dependent manner, following exposure times of 24 and 48 h at concentrations of 1 or 10 μM. The K+/SDS assay showed the formation of protein/DNA complexes after a 1 h exposure to 1 or 10 μM XR11576. Conclusion: Our data confirm that XR11576 or XR5944 can form topoisomerase complexes, after long periods of exposure. © 2008 Springer-Verlag.
Author(s): Jobson, A., Willmore, E., Tilby, M.J., Mistry, P., Charlton, P, Austin, C.
Publication type: Article
Publication status: Published
Journal: Cancer Chemotherapy and Pharmacology
Print publication date: 01/01/2008
ISSN (print): 0344-5704
ISSN (electronic): 1432-0843
Altmetrics provided by Altmetric